{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:32:23Z","timestamp":1790202743745,"version":"4.1.0"},"reference-count":185,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e9 Paul Sabatier"},{"name":"ANR (SphingoDR program)"},{"DOI":"10.13039\/100007860","name":"RITC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007860","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LNCC (Equipe Labellis\u00e9e 2013)"},{"name":"CHU Toulouse"},{"name":"Vaincre les Maladies Lysosomales Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbalip.2015.01.010","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T15:30:11Z","timestamp":1423323011000},"page":"1040-1051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Monogenic neurological disorders of sphingolipid metabolism"],"prefix":"10.1016","volume":"1851","author":[{"given":"Fr\u00e9d\u00e9rique","family":"Sabourdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Colacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dubot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-1889","authenticated-orcid":false,"given":"Bruno","family":"S\u00e9gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Andrieu-Abadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Levade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbalip.2015.01.010_bb0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbalip.2011.06.009","article-title":"Lipid classification, structures and tools","volume":"1811","author":"Fahy","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0163-7827(85)90011-6","article-title":"Lipids of nervous tissue: composition and metabolism","volume":"24","author":"Sastry","year":"1985","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)34198-5","article-title":"Role of sphingolipid-mediated cell death in neurodegenerative diseases","volume":"39","author":"Ariga","year":"1998","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1043-6618(03)00049-5","article-title":"The roles of ceramide and complex sphingolipids in neuronal cell function","volume":"47","author":"Buccoliero","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2004.07.014","article-title":"Sphingolipid metabolites in neural signalling and function","volume":"46","author":"Colombaioni","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"12","key":"10.1016\/j.bbalip.2015.01.010_bb0030","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.bbamem.2006.09.018","article-title":"Sphingolipids in apoptosis, survival and regeneration in the nervous system","volume":"1758","author":"Posse de Chaves","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cellsig.2008.07.011","article-title":"Sphingosine kinase\/sphingosine 1-phosphate signalling in central nervous system","volume":"21","author":"Okada","year":"2009","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.bbalip.2015.01.010_bb0040","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbalip.2010.05.003","article-title":"Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis","volume":"1801","author":"Haughey","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s11064-011-0692-y","article-title":"The roles of neutral sphingomyelinases in neurological pathologies","volume":"37","author":"Horres","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-3-7091-1511-4_21","article-title":"Sphingolipids in neuroinflammation","volume":"216","author":"Davies","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1388-1981(99)00002-5","article-title":"Organization of ganglioside synthesis in the Golgi apparatus","volume":"1437","author":"Maccioni","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"29","key":"10.1016\/j.bbalip.2015.01.010_bb0060","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.R200001200","article-title":"Combinatorial ganglioside biosynthesis","volume":"277","author":"Kolter","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbalip.2015.01.010_bb0065","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamem.2006.06.009","article-title":"Sphingolipid metabolism in neural cells","volume":"1758","author":"van Echten-Deckert","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol. Rev."},{"issue":"3\u20134","key":"10.1016\/j.bbalip.2015.01.010_bb0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0300-9084(03)00047-6","article-title":"Salvage pathways in glycosphingolipid metabolism","volume":"85","author":"Tettamanti","year":"2003","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.bbalip.2015.01.010_bb0080","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","article-title":"Lysosomal degradation of membrane lipids","volume":"584","author":"Kolter","year":"2010","journal-title":"FEBS Lett."},{"issue":"35","key":"10.1016\/j.bbalip.2015.01.010_bb0085","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1074\/jbc.R600010200","article-title":"When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis","volume":"281","author":"Pewzner-Jung","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0090","first-page":"135","article-title":"The longevity assurance homologue of yeast lag1 (Lass) gene family (review)","volume":"23","author":"Teufel","year":"2009","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24170","article-title":"Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy","volume":"76","author":"Vanni","year":"2014","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0110","doi-asserted-by":"crossref","first-page":"e1002063","DOI":"10.1371\/journal.pgen.1002063","article-title":"A deficiency of ceramide biosynthesis causes cerebellar Purkinje cell neurodegeneration and lipofuscin accumulation","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet."},{"issue":"50","key":"10.1016\/j.bbalip.2015.01.010_bb0115","doi-asserted-by":"crossref","first-page":"41888","DOI":"10.1074\/jbc.M112.413500","article-title":"Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes","volume":"287","author":"Ginkel","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/acn3.28","article-title":"Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy","volume":"1","author":"Mosbech","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"14","key":"10.1016\/j.bbalip.2015.01.010_bb0125","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1074\/jbc.M109.077610","article-title":"A critical role for ceramide synthase 2 in liver homeostasis: II. Insights into molecular changes leading to hepatopathy","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.bbalip.2015.01.010_bb0130","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1074\/jbc.M109.077594","article-title":"A critical role for ceramide synthase 2 in liver homeostasis: I. Alterations in lipid metabolic pathways","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.bbalip.2015.01.010_bb0135","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","article-title":"Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas","volume":"284","author":"Imgrund","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.bbalip.2015.01.010_bb0140","doi-asserted-by":"crossref","first-page":"30022","DOI":"10.1074\/jbc.M111.261206","article-title":"Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels","volume":"286","author":"Ben-David","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1471-4159.2005.03376.x","article-title":"Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study","volume":"95","author":"Hermansson","year":"2005","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2990.2011.01233.x","article-title":"Galactolipid deficiency in the early pathogenesis of neuronal ceroid lipofuscinosis model Cln8mnd: implications to delayed myelination and oligodendrocyte maturation","volume":"38","author":"Kuronen","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"8","key":"10.1016\/j.bbalip.2015.01.010_bb0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0968-0004(02)02154-0","article-title":"TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?","volume":"27","author":"Winter","year":"2002","journal-title":"Trends Biochem. Sci."},{"issue":"9","key":"10.1016\/j.bbalip.2015.01.010_bb0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","article-title":"Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate","volume":"1781","author":"Mao","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2015.01.010_bb0165","series-title":"Scriver's OMMBID (Online Metabolic and Molecular Bases of Inherited Disease)","article-title":"Acid ceramidase deficiency: Farber lipogranulomatosis","author":"Levade","year":"2009"},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cge.12307","article-title":"Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy","volume":"86","author":"Dyment","year":"2014","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0180","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0185","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/S0021-9258(19)50733-5","article-title":"Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene","volume":"267","author":"Schnabel","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbalip.2015.01.010_bb0190","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation","volume":"10","author":"Hulkova","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2005-865608","article-title":"Prosaposin deficiency \u2014 a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient","volume":"36","author":"Elleder","year":"2005","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations","volume":"149A","author":"Kuchar","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0205","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/abbi.1994.1248","article-title":"Stimulation of acid ceramidase activity by saposin D","volume":"311","author":"Azuma","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.bbalip.2015.01.010_bb0210","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1074\/jbc.M006846200","article-title":"Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins","volume":"276","author":"Linke","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.bbalip.2015.01.010_bb0215","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/ddh281","article-title":"Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse","volume":"13","author":"Matsuda","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","article-title":"Natural history of Type A Niemann\u2013Pick disease: possible endpoints for therapeutic trials","volume":"66","author":"McGovern","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2015.01.010_bb0225","series-title":"Scriver's OMMBID (Online Metabolic and Molecular Bases of Inherited Disease)","article-title":"Niemann\u2013Pick disease Types A and B: acid sphingomyelinase deficiencies","author":"Schuchman","year":"2009"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1022501702403","article-title":"Sphingosylphosphorylcholine in Niemann\u2013Pick disease brain: accumulation in type A but not in type B","volume":"24","author":"Rodriguez-Lafrasse","year":"1999","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0235","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann\u2013Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.bbalip.2015.01.010_bb0240","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0092-8674(05)80010-8","article-title":"Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann\u2013Pick disease)","volume":"81","author":"Otterbach","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1471-4159.2008.05591.x","article-title":"Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice","volume":"107","author":"Scandroglio","year":"2008","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1091\/mbc.E07-05-0439","article-title":"Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase","volume":"19","author":"Galvan","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0255","doi-asserted-by":"crossref","first-page":"e5310","DOI":"10.1371\/journal.pone.0005310","article-title":"Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18","volume":"4","author":"Camoletto","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0260","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-4159.2010.07034.x","article-title":"Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice","volume":"116","author":"Ledesma","year":"2011","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0265","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/emmm.201302649","article-title":"Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model","volume":"6","author":"Arroyo","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0270","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/cdd.2014.4","article-title":"High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A","volume":"21","author":"Gabande-Rodriguez","year":"2014","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0275","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajhg.2008.10.010","article-title":"Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia","volume":"83","author":"Edvardson","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"39","key":"10.1016\/j.bbalip.2015.01.010_bb0280","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1523\/JNEUROSCI.0458-08.2008","article-title":"Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration","volume":"28","author":"Zoller","year":"2008","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0285","doi-asserted-by":"crossref","first-page":"E1251","DOI":"10.1002\/humu.21205","article-title":"Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35)","volume":"31","author":"Dick","year":"2010","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.22122","article-title":"Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA)","volume":"68","author":"Kruer","year":"2010","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.bbalip.2015.01.010_bb0295","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/glia.21172","article-title":"Central nervous system dysfunction in a mouse model of FA2H deficiency","volume":"59","author":"Potter","year":"2011","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2009.12.004","article-title":"Fatty acid 2-Hydroxylation in mammalian sphingolipid biology","volume":"1801","author":"Hama","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2015.01.010_bb0305","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archneur.1965.00460290003001","article-title":"Metachromatic form of diffuse cerebral sclerosis. Iv. Low sulfatase activity in the urine of nine living patients with metachromatic leukodystrophy (Mld)","volume":"12","author":"Austin","year":"1965","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0310","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0006-291X(65)90137-3","article-title":"Evidence for the genetic block in metachromatic leucodystrophy (Ml)","volume":"19","author":"Mehl","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0315","series-title":"Scriver's OMMBID (Online Metabolic and Molecular Bases of Inherited Disease)","article-title":"Metachromatic leukodystrophy","author":"Gieselmann","year":"2009"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0320","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0325","first-page":"103","article-title":"Clinical aspects of globoid cell and metachromatic leukodystrophies","volume":"7","author":"Hagberg","year":"1971","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0330","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0005-2744(77)90288-1","article-title":"The activator of cerebroside sulphatase. Binding studies with enzyme and substrate demonstrating the detergent function of the activator protein","volume":"481","author":"Fischer","year":"1977","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbalip.2015.01.010_bb0335","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1073\/pnas.87.7.2541","article-title":"Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect","volume":"87","author":"Kretz","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0340","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0006-291X(90)90912-7","article-title":"Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy","volume":"166","author":"Rafi","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0345","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1023\/A:1005471106088","article-title":"Metachromatic leukodystrophy: molecular genetics and an animal model","volume":"21","author":"Gieselmann","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0350","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1471-4159.1989.tb01844.x","article-title":"Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain","volume":"52","author":"Rosengren","year":"1989","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0355","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0006-291X(89)90037-5","article-title":"Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy","volume":"159","author":"Toda","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"25","key":"10.1016\/j.bbalip.2015.01.010_bb0360","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","article-title":"Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy","volume":"93","author":"Hess","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"34","key":"10.1016\/j.bbalip.2015.01.010_bb0365","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1523\/JNEUROSCI.2329-07.2007","article-title":"Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy","volume":"27","author":"Eckhardt","year":"2007","journal-title":"J. Neurosci."},{"issue":"35","key":"10.1016\/j.bbalip.2015.01.010_bb0370","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1523\/JNEUROSCI.2287-07.2007","article-title":"Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy","volume":"27","author":"Ramakrishnan","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0030-1253412","article-title":"Metachromatic leukodystrophy \u2014 an update","volume":"41","author":"Gieselmann","year":"2010","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0380","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-4159.1974.tb11584.x","article-title":"Galactosylsphingosine galactosyl hydrolase in rat brain: probable identity with galactosylceramide galactosyl hydrolase","volume":"22","author":"Miyatake","year":"1974","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0385","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-8993(80)90159-6","article-title":"The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease)","volume":"202","author":"Kobayashi","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0390","series-title":"Scriver's OMMBID (Online Metabolic and Molecular Bases of Inherited Disease)","article-title":"Krabbe disease (Globoid Cell Leukodystrophy)","author":"Wenger","year":"2009"},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00401-011-0814-2","article-title":"Axonopathy is a compounding factor in the pathogenesis of Krabbe disease","volume":"122","author":"Castelvetri","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0400","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-2275(20)39839-4","article-title":"Krabbe disease: a galactosylsphingosine (psychosine) lipidosis","volume":"21","author":"Svennerholm","year":"1980","journal-title":"J. Lipid Res."},{"issue":"4650","key":"10.1016\/j.bbalip.2015.01.010_bb0405","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.6719111","article-title":"Progressive accumulation of toxic metabolite in a genetic leukodystrophy","volume":"224","author":"Igisu","year":"1984","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0410","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1046\/j.1471-4159.2003.01941.x","article-title":"Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line","volume":"86","author":"Haq","year":"2003","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0415","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2003.12.126","article-title":"Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation","volume":"358","author":"Zaka","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2013.02.024","article-title":"Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease","volume":"1508","author":"Won","year":"2013","journal-title":"Brain Res."},{"issue":"Pt 9","key":"10.1016\/j.bbalip.2015.01.010_bb0425","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/brain\/awt215","article-title":"Inhibition of angiogenesis by beta-galactosylceramidase deficiency in globoid cell leukodystrophy","volume":"136","author":"Belleri","year":"2013","journal-title":"Brain"},{"issue":"19","key":"10.1016\/j.bbalip.2015.01.010_bb0430","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1523\/JNEUROSCI.5597-08.2009","article-title":"Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture","volume":"29","author":"White","year":"2009","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbalip.2015.01.010_bb0435","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1194\/jlr.M039610","article-title":"Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture","volume":"54","author":"Hawkins-Salsbury","year":"2013","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0440","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1471-4159.2008.05279.x","article-title":"The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease","volume":"105","author":"Giri","year":"2008","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0445","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jnr.20529","article-title":"Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease","volume":"80","author":"Khan","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0450","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/path.4328","article-title":"Neuronal inclusions of alpha-synuclein contribute to the pathogenesis of Krabbe disease","volume":"232","author":"Smith","year":"2014","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0455","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2004.10.004","article-title":"A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans","volume":"84","author":"Spiegel","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.bbalip.2015.01.010_bb0460","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/hmg\/10.11.1191","article-title":"A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse","volume":"10","author":"Matsuda","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2015.01.010_bb0465","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1471-4159.2007.04709.x","article-title":"The function of sphingolipids in the nervous system: lessons learnt from mouse models of specific sphingolipid activator protein deficiencies","volume":"103","author":"Matsuda","year":"2007","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bbalip.2015.01.010_bb0470","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0475","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/ejhg.2012.202","article-title":"Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency","volume":"21","author":"Fragaki","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0480","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ajmg.a.35826","article-title":"Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency","volume":"161A","author":"Wang","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0485","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/hmg\/ddt434","article-title":"A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation","volume":"23","author":"Boccuto","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0490","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","article-title":"Enhanced insulin sensitivity in mice lacking ganglioside GM3","volume":"100","author":"Yamashita","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0495","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bbrc.2011.02.071","article-title":"Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice","volume":"406","author":"Niimi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.bbalip.2015.01.010_bb0500","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1073\/pnas.0903279106","article-title":"Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti","volume":"106","author":"Yoshikawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0505","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","article-title":"Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia","volume":"93","author":"Boukhris","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0510","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/jmg.2004.020172","article-title":"A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1\u201312q14","volume":"42","author":"Wilkinson","year":"2005","journal-title":"J. Med. Genet."},{"issue":"Pt 12","key":"10.1016\/j.bbalip.2015.01.010_bb0515","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/brain\/awt270","article-title":"Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis","volume":"136","author":"Harlalka","year":"2013","journal-title":"Brain"},{"issue":"20","key":"10.1016\/j.bbalip.2015.01.010_bb0520","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.93.20.10662","article-title":"Mice with disrupted GM2\/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system","volume":"93","author":"Takamiya","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.bbalip.2015.01.010_bb0525","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects","volume":"96","author":"Sheikh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0530","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","article-title":"A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice","volume":"166","author":"Chiavegatto","year":"2000","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0535","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0540","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-2275(20)38922-7","article-title":"Brain ceramide hexosides in Tay\u2013Sachs disease and generalized gangliosidosis (GM1-gangliosidosis)","volume":"8","author":"Suzuki","year":"1967","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0545","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005072-196901000-00003","article-title":"Chemical pathology of Gm1-gangliosidosis (generalized gangliosidosis)","volume":"28","author":"Suzuki","year":"1969","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0550","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0555","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molcel.2004.08.029","article-title":"GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis","volume":"15","author":"Tessitore","year":"2004","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0560","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.cdd.4401834","article-title":"Gangliosides as apoptotic signals in ER stress response","volume":"13","author":"d'Azzo","year":"2006","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0565","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbrc.2007.12.187","article-title":"Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis","volume":"367","author":"Takamura","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0570","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molcel.2009.10.021","article-title":"GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis","volume":"36","author":"Sano","year":"2009","journal-title":"Mol. Cell"},{"issue":"Pt 4","key":"10.1016\/j.bbalip.2015.01.010_bb0575","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0580","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-004-0848-9","article-title":"The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction","volume":"107","author":"van der Voorn","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0585","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-865863","article-title":"Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders","volume":"36","author":"Di Rocco","year":"2005","journal-title":"Neuropediatrics"},{"issue":"Suppl. 3","key":"10.1016\/j.bbalip.2015.01.010_bb0590","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1007\/PL00014401","article-title":"Population-based genetic screening for reproductive counseling: the Tay\u2013Sachs disease model","volume":"159","author":"Kaback","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0595","series-title":"Scriver's OMMBID (Online Metabolic and Molecular Bases of Inherited Disease)","article-title":"The GM2 gangliosidoses","author":"Gravel","year":"2009"},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0600","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"118","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0605","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","article-title":"Late-onset Tay\u2013Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients","volume":"7","author":"Neudorfer","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.bbalip.2015.01.010_bb0610","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00005072-196301000-00003","article-title":"Studies in Tay\u2013Sachs disease. II. Ultrastructure of the cerebrum","volume":"22","author":"Terry","year":"1963","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5687","key":"10.1016\/j.bbalip.2015.01.010_bb0615","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/276520a0","article-title":"Ectopic dendritic growth in mature pyramidal neurones in human ganglioside storage disease","volume":"276","author":"Purpura","year":"1978","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bbalip.2015.01.010_bb0620","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","article-title":"Enzyme alterations and lipid storage in three variants of Tay\u2013Sachs disease","volume":"18","author":"Sandhoff","year":"1971","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0625","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.1987.tb00969.x","article-title":"Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay\u2013Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?","volume":"49","author":"Rosengren","year":"1987","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0630","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(83)90415-8","article-title":"Characterization of some minor gangliosides in Tay\u2013Sachs brains","volume":"275","author":"Yu","year":"1983","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0635","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0024-3205(68)90024-6","article-title":"Deficient hexozaminidase activity in an exceptional case of Tay\u2013Sachs disease with additional storage of kidney globoside in visceral organs","volume":"7","author":"Sandhoff","year":"1968","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0640","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00005176-200105000-00021","article-title":"Primary non-Hodgkin lymphoma of the extrahepatic biliary tract and gallbladder in a child","volume":"32","author":"Gravel","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0645","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1440-1754.2002.00765.x","article-title":"Cardiac involvement in infantile Sandhoff disease","volume":"38","author":"Venugopalan","year":"2002","journal-title":"J. Paediatr. Child Health"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0650","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay\u2013Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.bbalip.2015.01.010_bb0655","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.bbalip.2015.01.010_bb0660","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1073\/pnas.0400625101","article-title":"Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2015.01.010_bb0665","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1742-2094-9-186","article-title":"Conditional expression of human beta-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation","volume":"9","author":"Kyrkanides","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.bbalip.2015.01.010_bb0670","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10409239009090616","article-title":"Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease","volume":"25","author":"Grabowski","year":"1990","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"9645","key":"10.1016\/j.bbalip.2015.01.010_bb0675","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0680","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.braindev.2005.04.005","article-title":"Type 2 Gaucher disease: 15 new cases and review of the literature","volume":"28","author":"Mignot","year":"2006","journal-title":"Brain Dev."},{"issue":"23\u201324","key":"10.1016\/j.bbalip.2015.01.010_bb0685","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10354-010-0850-x","article-title":"Neuropathic Gaucher disease","volume":"160","author":"Pastores","year":"2010","journal-title":"Wien. Med. Wochenschr."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0690","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","article-title":"A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients","volume":"33","author":"Kraoua","year":"2011","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0695","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0700","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0705","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0004.1982.tb01445.x","article-title":"Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III","volume":"22","author":"Nilsson","year":"1982","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0710","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0715","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher's disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bbalip.2015.01.010_bb0720","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/07853890.2013.849003","article-title":"Glucocerebrosidase mutations and the pathogenesis of Parkinson disease","volume":"45","author":"Beavan","year":"2013","journal-title":"Ann. Med."},{"issue":"15","key":"10.1016\/j.bbalip.2015.01.010_bb0725","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"Xu","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0730","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","article-title":"Mutations in GBA2 cause autosomal\u2013recessive cerebellar ataxia with spasticity","volume":"92","author":"Hammer","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.bbalip.2015.01.010_bb0735","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0740","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"Martin","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.bbalip.2015.01.010_bb0745","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0750","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.3021","article-title":"The cellular pathology of lysosomal diseases","volume":"226","author":"Cox","year":"2012","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0755","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbalip.2008.01.004","article-title":"Functions of sphingolipid metabolism in mammals \u2014 lessons from genetic defects","volume":"1781","author":"Sabourdy","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbalip.2015.01.010_bb0760","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R003996","article-title":"Multi-system disorders of glycosphingolipid and ganglioside metabolism","volume":"51","author":"Xu","year":"2010","journal-title":"J. Lipid Res."},{"issue":"27","key":"10.1016\/j.bbalip.2015.01.010_bb0765","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7503","key":"10.1016\/j.bbalip.2015.01.010_bb0770","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature13476","article-title":"Sphingolipid lysosomal storage disorders","volume":"510","author":"Platt","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0775","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0306-4522(99)00288-2","article-title":"Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes","volume":"94","author":"Moore","year":"1999","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0780","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/glia.10180","article-title":"Sphingosine 1-phosphate induces the production of glial cell line-derived neurotrophic factor and cellular proliferation in astrocytes","volume":"41","author":"Yamagata","year":"2003","journal-title":"Glia"},{"issue":"1\u20132","key":"10.1016\/j.bbalip.2015.01.010_bb0785","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11010-007-9524-4","article-title":"Production of nerve growth factor enhanced in cultured mouse astrocytes by glycerophospholipids, sphingolipids, and their related compounds","volume":"305","author":"Furukawa","year":"2007","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0790","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3835(02)00050-2","article-title":"Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta","volume":"181","author":"Van Brocklyn","year":"2002","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.bbalip.2015.01.010_bb0795","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.09-150540","article-title":"Role of sphingosine kinase-1 in paracrine\/transcellular angiogenesis and lymphangiogenesis in vitro","volume":"24","author":"Anelli","year":"2010","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0800","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2006-0223","article-title":"Essential roles of sphingosine 1-phosphate\/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury","volume":"25","author":"Kimura","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbalip.2015.01.010_bb0805","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/ncomms5859","article-title":"Hypothalamic S1P\/S1PR1 axis controls energy homeostasis","volume":"5","author":"Silva","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbalip.2015.01.010_bb0810","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/glia.22718","article-title":"Autocrine\/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells","volume":"62","author":"Marfia","year":"2014","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0815","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.RES.0000026057.13161.42","article-title":"Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C","volume":"91","author":"Shirao","year":"2002","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0820","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0278-5846(99)00047-0","article-title":"Lysosphingomyelin prevents behavioral aberrations and hippocampal neuron loss induced by the metabotropic glutamate receptor agonist quisqualate","volume":"23","author":"Hodgson","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0825","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1523\/JNEUROSCI.23-03-00907.2003","article-title":"Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development","volume":"23","author":"Ignatov","year":"2003","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0830","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1460-9568.2007.05732.x","article-title":"Sphingosylphosphocholine effects on cultured astrocytes reveal mechanisms potentially involved in neurotoxicity in Niemann\u2013Pick type A disease","volume":"26","author":"Chiulli","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0835","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1074\/jbc.273.1.242","article-title":"Sphingosine inhibits voltage-operated calcium channels in GH4C1 cells","volume":"273","author":"Titievsky","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbalip.2015.01.010_bb0840","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/jcp.22571","article-title":"Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3\/-9 via a mitochondrial pathway linked to SDK\/14-3-3 protein\/Bax\/cytochrome c","volume":"226","author":"Kanno","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.bbalip.2015.01.010_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)00508-3","article-title":"Psychosine blocks quisqualate-induced glutamate excitotoxicity in hippocampal CA sector neurons","volume":"802","author":"Hodgson","year":"1998","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbalip.2015.01.010_bb0850","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(02)00655-9","article-title":"Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine","volume":"330","author":"Jatana","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"24","key":"10.1016\/j.bbalip.2015.01.010_bb0855","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1523\/JNEUROSCI.0217-13.2013","article-title":"The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3beta and deregulation of molecular motors","volume":"33","author":"Cantuti Castelvetri","year":"2013","journal-title":"J. Neurosci."},{"issue":"26","key":"10.1016\/j.bbalip.2015.01.010_bb0860","doi-asserted-by":"crossref","first-page":"23594","DOI":"10.1074\/jbc.M300212200","article-title":"Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms","volume":"278","author":"Lloyd-Evans","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0865","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3","volume":"14","author":"Schueler","year":"2003","journal-title":"Neurobiol. Dis."},{"issue":"45","key":"10.1016\/j.bbalip.2015.01.010_bb0870","doi-asserted-by":"crossref","first-page":"26868","DOI":"10.1074\/jbc.270.45.26868","article-title":"A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation","volume":"270","author":"Riboni","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0875","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/73171","article-title":"Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation","volume":"6","author":"Galve-Roperh","year":"2000","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbalip.2015.01.010_bb0880","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004647-200101000-00005","article-title":"The protective effect of ceramide in immature rat brain hypoxia\u2013ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells","volume":"21","author":"Chen","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"12","key":"10.1016\/j.bbalip.2015.01.010_bb0885","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1158\/0008-5472.CAN-03-3084","article-title":"Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells","volume":"64","author":"Daido","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbalip.2015.01.010_bb0890","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI37948","article-title":"Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells","volume":"119","author":"Salazar","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbalip.2015.01.010_bb0895","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0361-9230(02)00772-4","article-title":"Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke","volume":"58","author":"Altura","year":"2002","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.bbalip.2015.01.010_bb0900","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bbalip.2015.01.010_bb0905","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1021\/pr4003432","article-title":"2\u2032-hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells","volume":"12","author":"Kota","year":"2013","journal-title":"J. Proteome Res."},{"issue":"19","key":"10.1016\/j.bbalip.2015.01.010_bb0910","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1073\/pnas.85.19.7351","article-title":"Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex","volume":"85","author":"Favaron","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbalip.2015.01.010_bb0915","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0197-0186(02)00103-1","article-title":"Sulfatide and GM1 ganglioside modulate the high-affinity dopamine uptake in rat striatal synaptosomes: evidence for the involvement of their ionic charges","volume":"42","author":"Barrier","year":"2003","journal-title":"Neurochem. Int."},{"issue":"39","key":"10.1016\/j.bbalip.2015.01.010_bb0920","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1523\/JNEUROSCI.1149-14.2014","article-title":"Ganglioside regulation of AMPA receptor trafficking","volume":"34","author":"Prendergast","year":"2014","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bbalip.2015.01.010_bb0925","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/cercor\/10.10.1028","article-title":"Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons","volume":"10","author":"Walkley","year":"2000","journal-title":"Cereb. Cortex"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198115000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198115000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T02:21:50Z","timestamp":1717726910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198115000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":185,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1388198115000189"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2015.01.010","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monogenic neurological disorders of sphingolipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2015.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}